NGNE

Neurogene Inc.

Insider Trades

NameValueActionPriceCurrent Price
Cvijic Christine MikailDirector, Officer: President And CFO
$156k4.8k shares
SellMay 6, 2026
$32.44
--
Cvijic Christine MikailDirector, Officer: President And CFO
$144k4.8k shares
SellMay 6, 2026
$30.07
--
McMinn RachelDirector, Officer: Chief Executive Officer
$74k3.4k shares
SellMar 26, 2026
$22.07
--
Cvijic Christine MikailPresident And CFO
$55k2.6k shares
SellMar 26, 2026
$21.62
--
Jordan JulieChief Medical Officer
$18k828 shares
SellMar 26, 2026
$21.89
--
Cobb StuartChief Scientific Officer
$3.3k148 shares
SellMar 13, 2026
$22.08
--

News

gurufocus.comNeurogene Announces Successful Completion of Dosing in Embolden™ Registrational Trial of NGN-401 for Rett Syndromegurufocus.comJun 8businesswire.comNeurogene Announces Successful Completion of Dosing in Embolden™ Registrational Trial of NGN-401 for Rett Syndromebusinesswire.comJun 8businesswire.comNeurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)businesswire.comJun 2businesswire.comNeurogene Reports First Quarter 2026 Financial Results and Highlights Recent Updatesbusinesswire.comMay 12businesswire.comNeurogene Highlights Data at ASGCT Meeting Supporting Therapeutic Rationale for ICV Delivery Method in CNS-targeted Gene Therapybusinesswire.comMay 12